Form 8-K - Current report:
SEC Accession No. 0001640334-25-000210
Filing Date
2025-02-07
Accepted
2025-02-07 16:36:38
Documents
20
Period of Report
2025-02-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bdpt_8k.htm   iXBRL 8-K 18330
2 PRESS RELEASE bdpt_ex991a.htm EX-99.1A 10299
3 PRESS RELEASE bdpt_ex991b.htm EX-99.1B 8129
9 bdpt_8kimg4.jpg GRAPHIC 4814
10 bdpt_ex991aimg1.jpg GRAPHIC 5323
11 bdpt_ex991bimg1.jpg GRAPHIC 5331
  Complete submission text file 0001640334-25-000210.txt   184890

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bdpt-20250203.xsd EX-101.SCH 5874
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdpt-20250203_lab.xml EX-101.LAB 13171
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bdpt-20250203_cal.xml EX-101.CAL 898
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdpt-20250203_pre.xml EX-101.PRE 8249
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bdpt-20250203_def.xml EX-101.DEF 2099
23 EXTRACTED XBRL INSTANCE DOCUMENT bdpt_8k_htm.xml XML 3537
Mailing Address 2620 REGATTA DRIVE SUITE 102 LAS VEGAS NV 89128
Business Address 2620 REGATTA DRIVE SUITE 102 LAS VEGAS NV 89128 (702) 659-8829
BIOADAPTIVES, INC. (Filer) CIK: 0001575142 (see all company filings)

EIN.: 462592228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54949 | Film No.: 25602446
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)